Phase
Condition
Myocardial Ischemia
Coronary Artery Disease
Thrombosis
Treatment
EucaLimus coronary stent system
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Consecutive patients intended to be, or treated by EucaLimus as per physicians'decision and according to Instructions for Use (IFU) in the setting of routineclinical care are entered into the registry.
Exclusion
Exclusion Criteria:
Patients are excluded from registration if ANY of the following conditions apply:
High probability of non-adherence to the follow-up requirements (due to social,psychological or medical reasons)
Currently participating in another investigational drug or device study inwhich a routine angiographic follow-up is planned
A life expectancy of <1year
Explicit refusal of participation in the registry
Study Design
Study Description
Connect with a study center
Krajska nemocnice Liberec
Liberec, 46001
Czech RepublicActive - Recruiting
Motol University Hospital
Prague, 15006
Czech RepublicActive - Recruiting
Institut Jantung Negara
Kuala Lumpur, 50400
MalaysiaActive - Recruiting
Bellvitge University Hospital
L'Hospitalet de Llobregat, Catalonia 08907
SpainActive - Recruiting
Hospital de la Santa Creu i Sant Pau
Barcelona, 08026
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.